Pressroom
-
Biosimilars Drug Market Isn’t Broken After All, USC Schaeffer Study Finds
Researchers looked at cancer therapy trastuzumab (Herceptin) and found biosimilars bring competition to the market, with prices declining by more than half for some versions.
Categorized in -
Biosimilar Drugs Underutilized Due to Commercial Insurance Restrictions
The first study to examine biosimilar drivers finds commercial insurers limit use in almost 20% of cases.
Categorized in -
Schaeffer Research Director Testifies at Congressional Hearing on Biomedical Innovation and Patient Access
Darius Lakdawalla was part of a panel of experts called upon by the U.S. House Ways and Means Subcommittee on Health.
-
Medicare Coverage of Weight Loss Drugs Could Significantly Reduce Costs
USC Schaeffer white paper finds that increasing access to obesity treatments would help save lives and reduce healthcare costs.
Categorized in -
New Schaeffer White Paper Offers Solutions to Ensure Greater Patient Access to Prescription Drugs
The researchers propose three strategies for mitigating negative impacts of the Inflation Reduction Act to ensure greater patient access, increased innovation and lower costs.
Categorized in -
Senate Finance Committee Explores Costly, Secretive Practices in the Drug Supply Chain
Karen Van Nuys testified at the hearing, calling transparency “an essential first step.”
-
Prominent Health Executive Tom Priselac Named Vice Chair of Schaeffer Center Advisory Board
Priselac, who is CEO and president of Cedars-Sinai, has served on the board since its inception in 2011.
-
Medicare Advantage Enrollment Outpaces —and Nearly Overcomes— Traditional Medicare, New USC Study Finds
Medicare Advantage plans have seen a more than 300% increase in enrollment—with payment policy yet to catch up.
Categorized in -
False Confidence in Blood Pressure Knowledge Undermines Intentions to Seek Care
Most Americans don’t know the meaning of 120-80 mm Hg, but think they do.
Categorized in -
New Randomized Trial Shows Simple Letters Promote Better-Informed Opioid Prescribing
Letters successfully encouraged clinicians to check patients’ prescribing records, says study co-author Mireille Jacobson.
Categorized in